Veronika Hanušová

916 total citations
28 papers, 769 citations indexed

About

Veronika Hanušová is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Veronika Hanušová has authored 28 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Veronika Hanušová's work include Cancer Treatment and Pharmacology (6 papers), Natural product bioactivities and synthesis (5 papers) and Cancer therapeutics and mechanisms (4 papers). Veronika Hanušová is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Natural product bioactivities and synthesis (5 papers) and Cancer therapeutics and mechanisms (4 papers). Veronika Hanušová collaborates with scholars based in Czechia, United States and China. Veronika Hanušová's co-authors include Lenka Skálová, Věra Králová, Iva Boušová, Petra Matoušková, Martin Ambrož, Hana Bártíková, Barbora Szotáková, Adam Skarka, Emil Rudolf and Pavel Trachta and has published in prestigious journals such as PLoS ONE, Annals of Oncology and Molecules.

In The Last Decade

Veronika Hanušová

27 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Veronika Hanušová Czechia 16 406 120 98 88 88 28 769
Věra Králová Czechia 16 337 0.8× 122 1.0× 83 0.8× 89 1.0× 87 1.0× 28 683
Juthika Kundu South Korea 18 441 1.1× 134 1.1× 95 1.0× 51 0.6× 86 1.0× 26 926
Do Youn Jun South Korea 19 600 1.5× 165 1.4× 116 1.2× 55 0.6× 116 1.3× 58 1.0k
Linda Bertoncelli Italy 12 506 1.2× 108 0.9× 133 1.4× 45 0.5× 88 1.0× 16 1.2k
Shakti Prasad Pattanayak India 19 395 1.0× 108 0.9× 85 0.9× 110 1.3× 214 2.4× 57 1.0k
Alexandre F. Aissa Brazil 19 438 1.1× 122 1.0× 143 1.5× 52 0.6× 127 1.4× 48 967
Kartick C. Pramanik United States 14 597 1.5× 202 1.7× 183 1.9× 75 0.9× 59 0.7× 24 1.0k
Wei Dong-zhi China 17 559 1.4× 129 1.1× 61 0.6× 44 0.5× 100 1.1× 45 878
Zhengquan Lai China 17 581 1.4× 69 0.6× 86 0.9× 48 0.5× 71 0.8× 34 931
Elżbieta Hrabec Poland 16 311 0.8× 106 0.9× 156 1.6× 77 0.9× 96 1.1× 29 784

Countries citing papers authored by Veronika Hanušová

Since Specialization
Citations

This map shows the geographic impact of Veronika Hanušová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronika Hanušová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronika Hanušová more than expected).

Fields of papers citing papers by Veronika Hanušová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronika Hanušová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronika Hanušová. The network helps show where Veronika Hanušová may publish in the future.

Co-authorship network of co-authors of Veronika Hanušová

This figure shows the co-authorship network connecting the top 25 collaborators of Veronika Hanušová. A scholar is included among the top collaborators of Veronika Hanušová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronika Hanušová. Veronika Hanušová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanušová, Veronika, et al.. (2018). Recirculation of sludge-water in the water treatment process – a pilot study. Water Practice & Technology. 13(3). 461–468. 1 indexed citations
2.
Králová, Věra, et al.. (2018). Flubendazole and mebendazole impair migration and epithelial to mesenchymal transition in oral cell lines. Chemico-Biological Interactions. 293. 124–132. 24 indexed citations
3.
Hanušová, Veronika, et al.. (2017). Role of E-cadherin in metastatic colorectal cancer treatment. Annals of Oncology. 28. vii28–vii28.
4.
Hanušová, Veronika, Hana Svobodová, Martin Ambrož, et al.. (2017). The effects of β-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice. Biomedicine & Pharmacotherapy. 95. 828–836. 68 indexed citations
5.
Hanušová, Veronika, et al.. (2017). Derivation and basic characterization of colorectal carcinoma primary cell lines. Biomedical Papers. 161(4). 360–368. 4 indexed citations
6.
Ambrož, Martin, Iva Boušová, Adam Skarka, et al.. (2015). The Influence of Sesquiterpenes from Myrica rubra on the Antiproliferative and Pro-Oxidative Effects of Doxorubicin and Its Accumulation in Cancer Cells. Molecules. 20(8). 15343–15358. 61 indexed citations
7.
Boušová, Iva, Petra Matoušková, Hana Bártíková, et al.. (2015). Influence of diet supplementation with green tea extract on drug-metabolizing enzymes in a mouse model of monosodium glutamate-induced obesity. European Journal of Nutrition. 55(1). 361–371. 15 indexed citations
8.
Hanušová, Veronika, Lenka Skálová, Věra Králová, & Petra Matoušková. (2015). Potential Anti-cancer Drugs Commonly Used for Other Indications. Current Cancer Drug Targets. 15(1). 35–52. 65 indexed citations
9.
Matoušková, Petra, Hana Bártíková, Iva Boušová, et al.. (2014). Reference Genes for Real-Time PCR Quantification of Messenger RNAs and MicroRNAs in Mouse Model of Obesity. PLoS ONE. 9(1). e86033–e86033. 53 indexed citations
10.
Hanušová, Veronika, et al.. (2014). Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro. Acta Pharmaceutica. 64(2). 199–209. 15 indexed citations
11.
Bártíková, Hana, Veronika Hanušová, Lenka Skálová, Martin Ambrož, & Iva Boušová. (2014). Antioxidant, Pro-Oxidant and Other Biological Activities of Sesquiterpenes. Current Topics in Medicinal Chemistry. 14(22). 2478–2494. 78 indexed citations
12.
Hanušová, Veronika, et al.. (2013). In vivo effect of oracin on doxorubicin reduction, biodistribution and efficacy in Ehrlich tumor bearing mice. Pharmacological Reports. 65(2). 445–452. 3 indexed citations
13.
Králová, Věra, et al.. (2013). Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines. Anti-Cancer Drugs. 24(9). 911–919. 58 indexed citations
14.
Kaválková, Petra, I Dostálová, D Haluzíková, et al.. (2012). Preadipocyte Factor-1 Concentrations in Patients With Anorexia Nervosa: the Influence of Partial Realimentation. Physiological Research. 61(2). 153–159. 7 indexed citations
15.
Hanušová, Veronika, et al.. (2012). The influence of oracin on reduction and toxicity of doxorubicin in hepatocytes and mammary epithelial cells MCF-10A. Xenobiotica. 42(6). 571–579. 2 indexed citations
16.
Dvořáková, Marcela, et al.. (2011). Paclitaxel conjugation with the analog of the gonadotropin-releasing hormone as a targeting moiety. International Journal of Pharmaceutics. 415(1-2). 175–180. 5 indexed citations
17.
Hanušová, Veronika, Iva Boušová, & Lenka Skálová. (2011). Possibilities to increase the effectiveness of doxorubicin in cancer cells killing. Drug Metabolism Reviews. 43(4). 540–557. 73 indexed citations
18.
Lamka, J., et al.. (2011). Factors affecting pharmacokinetics of benzimidazole anthelmintics in food-producing animals: The consequences and potential risks. Research in Veterinary Science. 91(3). 333–341. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026